Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6158226rdf:typepubmed:Citationlld:pubmed
pubmed-article:6158226lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:6158226lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:6158226lifeskim:mentionsumls-concept:C0022245lld:lifeskim
pubmed-article:6158226lifeskim:mentionsumls-concept:C1510802lld:lifeskim
pubmed-article:6158226lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:6158226lifeskim:mentionsumls-concept:C2612945lld:lifeskim
pubmed-article:6158226pubmed:issue3lld:pubmed
pubmed-article:6158226pubmed:dateCreated1980-11-20lld:pubmed
pubmed-article:6158226pubmed:abstractTextLeukocyte adherence was examined in atopic and normal subjects and the influence of histamine and the beta-adrenergic agonist, isoproterenol, evaluated. Atopics included patients with mild to severe atopic dermatitis and patients with asthma and hayfever. No inter-group differences in leukocyte adherence of untreated leukocytes could be demonstrated, but there was a significantly smaller histamine and isoproterenol effect on the adherence of cells from patients with atopic dermatitis and hayfever. The induced inhibition of leukocyte adherence by histamine could be blocked by the H-2 histamine receptor antagonist, metiamide, suggesting that this effect may be mediated via cAMP. Our findings support the hypothesis that atopic dermatitis patients may have a defect or blockade of their cellular response to histamine.lld:pubmed
pubmed-article:6158226pubmed:languageenglld:pubmed
pubmed-article:6158226pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6158226pubmed:citationSubsetIMlld:pubmed
pubmed-article:6158226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6158226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6158226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6158226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6158226pubmed:statusMEDLINElld:pubmed
pubmed-article:6158226pubmed:issn0001-5555lld:pubmed
pubmed-article:6158226pubmed:authorpubmed-author:ThulinHHlld:pubmed
pubmed-article:6158226pubmed:authorpubmed-author:HanifinJ MJMlld:pubmed
pubmed-article:6158226pubmed:authorpubmed-author:BryantRRlld:pubmed
pubmed-article:6158226pubmed:issnTypePrintlld:pubmed
pubmed-article:6158226pubmed:volume60lld:pubmed
pubmed-article:6158226pubmed:ownerNLMlld:pubmed
pubmed-article:6158226pubmed:authorsCompleteYlld:pubmed
pubmed-article:6158226pubmed:pagination235-8lld:pubmed
pubmed-article:6158226pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:meshHeadingpubmed-meshheading:6158226-...lld:pubmed
pubmed-article:6158226pubmed:year1980lld:pubmed
pubmed-article:6158226pubmed:articleTitleLeukocyte adherence in atopic dermatitis: diminished responses to histamine and isoproterenol.lld:pubmed
pubmed-article:6158226pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6158226lld:pubmed